FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

719411008: Naloxegol (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3316074017 Naloxegol (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3316075016 Naloxegol en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naloxegol Is a Substance with opioid receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Naloxegol Is a Gastrointestinal agent true Inferred relationship Existential restriction modifier
Naloxegol Is a Substance with morphinan structure and opioid receptor agonist mechanism of action (substance) false Inferred relationship Existential restriction modifier
Naloxegol Has disposition Opioid receptor antagonist true Inferred relationship Existential restriction modifier
Naloxegol Has disposition Opioid receptor agonist false Inferred relationship Existential restriction modifier
Naloxegol Is a Morphinan true Inferred relationship Existential restriction modifier
Naloxegol Is a Antidote true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Naloxegol oxalate Is a False Naloxegol Inferred relationship Existential restriction modifier
Product containing naloxegol Has active ingredient True Naloxegol Inferred relationship Existential restriction modifier 1
Product containing naloxegol in oral dose form (medicinal product form) Has active ingredient True Naloxegol Inferred relationship Existential restriction modifier 1
Naloxegol Has active ingredient True Naloxegol Inferred relationship Existential restriction modifier 1
Product containing only naloxegol in oral dose form (medicinal product form) Has active ingredient True Naloxegol Inferred relationship Existential restriction modifier 1
Naloxegol oxalate Is modification of True Naloxegol Inferred relationship Existential restriction modifier
Product containing precisely naloxegol (as naloxegol oxalate) 25 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier 1
Product containing precisely naloxegol (as naloxegol oxalate) 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier 1
Naloxegol 12.5mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier
Moventig 12.5mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier
Moventig 25mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier
Moventig 12.5mg tablets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier
Moventig 25mg tablets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets Has basis of strength substance False Naloxegol Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets Has basis of strength substance False Naloxegol Inferred relationship Existential restriction modifier
Moventig 12.5mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets Has basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier
Moventig 25mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets Has basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets 30 tablet Has basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets 30 tablet Has basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier
Moventig 12.5mg tablets (AstraZeneca UK Ltd) Has basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier
Moventig 25mg tablets (AstraZeneca UK Ltd) Has basis of strength substance True Naloxegol Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start